Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Used only to estimate how many weeks the vial may last
Retatrutide (research grade), also designated LY3437943, is a long-acting synthetic peptide engineered to co-engage three distinct G-protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
The news: Novo Nordisk filed a patent infringement lawsuit against Hims & Hers, accusing the company of unlawfully mass-marketing Novos GLP-1 drug semaglutidethe active ingredient in Wegovy and Ozempic
Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, et al
With personalized care, expert oversight, and a commitment to your safety, were here to guide you every step of the way
